Download PDF
Int J Angiol 1998; 7(3): 191-196
DOI: 10.1007/BF01617391
Original Articles

© Georg Thieme Verlag KG Stuttgart · New York

What's new in lymphedema therapy in America?

Robert Lerner
  • State University of New York Health Science Center, Brooklyn, New York
Presented at the 16th Annual Congress, The Phlebology Society of America, New York, New York, March 1996.
Further Information

Publication History

Publication Date:
23 April 2011 (online)

  PDF Download  Permissions and Reprints

Abstract

There is much confusion among American medical professionals regarding the treatment of lymphedema. Much of it has to do with the fact that lymphedema “falls between the cracks” of all standard specialties in modern American practice. Partially for this reason and because of a general misconception among American physicians that lymphedema is not a “serious” problem, the condition has been virtually ignored and deprioritized for many decades. This study is intended to clarify the confusion and reasons for apathy toward the subject of lymphedema and its treatment.

Lymphedema, for the most part ignored or poorly treated in the United States, is currently being effectively treated by complete (or complex) decongestive physiotherapy (CDP) in many American facilities. CDP was introduced to the United States by the author in 1989 and is a gentle, effective, cost-effective, safe, and noninvasive treatment. It is and must be performed by specially trained therapists under the supervision of lymphologists with expertise in lymphedema, its diagnosis, treatment, complications, and natural history.

This article describes the author's experience in treating 1000 upper and 1000 lower extremity lymphedema patients by the CDP method. These patients were treated between 1989 and 1995 for an average of 25 tretments, each patient returning for a follow-up examination 1 year after the completion of his or her course of treatment. The variables recorded in this study were as follows: the patient's sex, type of lymphedema, and volumetric reduction achieved immediately following treatment and as measured 1 year after treatment. The therapy and follow-up procedures are explained in detail and examples (before and after photos) of actual cases are included.

Based on the results of this study and others, it is the author's opinion that CDP therapy is superior to any surgical procedures currently being used and to the pneumatic pump therapies often erroneously recommended for this condition.

      >